-
EP4217391
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4217391
| EP4217391 - NOVEL HUMAN ANTIBODIES BINDING TO HUMAN CD3 EPSILON [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 30.06.2023 Database last updated on 24.08.2024 | |
| Former | The international publication has been made Status updated on 02.04.2022 | ||
| Former | unknown Status updated on 11.10.2021 | Most recent event Tooltip | 01.12.2023 | Change: Validation states | published on 03.01.2024 [2024/01] | 01.12.2023 | Change - extension states | published on 03.01.2024 [2024/01] | Applicant(s) | For all designated states MorphoSys AG Semmelweisstrasse 7 82152 Planegg / DE | [2023/31] | Inventor(s) | 01 /
BÜLTMANN, Andreas 82152 Planegg / DE | 02 /
RUNZ, Steffen 69126 Heidelberg / DE | 03 /
BATAA, Tschimegma 80798 München / DE | 04 /
MOOSMEIER, Markus 94405 Landau a. d. Isar Thalham / DE | 05 /
HAUBST, Nicole 81475 München / DE | 06 /
KLATTIG, Jürgen 82380 Peißenberg / DE | 07 /
STARK, Yvonne 81379 München / DE | [2023/31] | Application number, filing date | 21782518.1 | 22.09.2021 | [2023/31] | WO2021EP76052 | Priority number, date | EP20200197975 | 24.09.2020 Original published format: EP 20197975 | [2023/31] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022063819 | Date: | 31.03.2022 | Language: | EN | [2022/13] | Type: | A1 Application with search report | No.: | EP4217391 | Date: | 02.08.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 31.03.2022 takes the place of the publication of the European patent application. | [2023/31] | Search report(s) | International search report - published on: | EP | 31.03.2022 | Classification | IPC: | C07K16/28, C07K16/32, C07K16/46, A61P35/00 | [2023/31] | CPC: |
C07K16/2809 (EP,IL,KR,US);
A61P35/00 (EP,IL,KR,US);
C07K16/2863 (EP,IL);
C07K16/32 (EP,IL,KR);
C07K16/468 (EP,IL);
A61K2039/505 (KR);
C07K2317/21 (EP,IL,KR);
C07K2317/31 (EP,IL,KR,US);
C07K2317/33 (EP,IL,KR,US);
C07K2317/55 (EP,IL,KR,US);
C07K2317/56 (EP,IL,KR);
C07K2317/565 (US);
C07K2317/60 (EP,IL,KR);
C07K2317/622 (US);
C07K2317/73 (EP,IL,KR);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/31] | Title | German: | NEUE HUMANE ANTIKÖRPER, DIE AN HUMANES CD3-EPSILON BINDEN | [2023/31] | English: | NOVEL HUMAN ANTIBODIES BINDING TO HUMAN CD3 EPSILON | [2023/31] | French: | NOUVEAUX ANTICORPS HUMAINS SE LIANT AU CD3 EPSILON HUMAIN | [2023/31] | Entry into regional phase | 24.04.2023 | National basic fee paid | 24.04.2023 | Designation fee(s) paid | 24.04.2023 | Examination fee paid | Examination procedure | 24.04.2023 | Examination requested [2023/31] | 24.04.2023 | Date on which the examining division has become responsible | 09.11.2023 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 26.09.2023 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [I]WO2008119567 (MICROMET AG [DE], et al) [I] 1-15 * claims 1-3, 11, 12 *; | [AD]WO2013104804 (UNIV WUERZBURG J MAXIMILIANS [DE]) [AD] 1-15 * figure 2 *; | [I]WO2015181098 (HOFFMANN LA ROCHE [CH], et al) [I] 1-15 * page 25 - page 27; claim 14 *; | [I]WO2019034580 (MORPHOSYS AG [DE]) [I] 1-15 * page 14; examples 1, 7; table 10 * * page 53 *; | [A] - SHIRA WARSZAWSKI ET AL, "Optimizing antibody affinity and stability by the automated design of the variable light-heavy chain interfaces", PLOS COMPUTATIONAL BIOLOGY, (20190823), vol. 15, no. 8, doi:10.1371/journal.pcbi.1007207, page e1007207, XP055680871 [A] 1-15 * the whole document * DOI: http://dx.doi.org/10.1371/journal.pcbi.1007207 | by applicant | US5641870 | US5821337 | US6136599 | WO0105950 | US6703199 | WO2008119567 | WO2013104804 | US8728981 | WO2019034580 | WO2020115115 | - YOSHINO N. et al., Exp. Anim, (20000000), vol. 49, pages 97 - 110 | - CONRAD ML et al., Cytometry, (20070000), vol. 71A, pages 925 - 33 | - "UniProt", Database accession no. Q95LI5 | - CHOTHIA et al., Nature, (19890000), vol. 342, pages 877 - 883 | - BIRD et al., Science, (19880000), vol. 242, pages 423 - 426 | - HUSTON et al., Proc. Natl. Acad. Sci., (19880000), vol. 85, pages 5879 - 5883 | - HOLLINGERHUDSON, Nature Biotechnology, (20050000), vol. 23, pages 1126 - 1136 | - ZAPATA et al., Protein Eng, (19950000), vol. 8, pages 1057 - 1062 | - KNAPPIK et al., J Mol Biol, (20000000), vol. 296, pages 57 - 86 | - TILLER et al., mAbs, (20130500), vol. 5, no. 3, pages 1 - 26 | - LAZIKANI et al., J. Mol. Bio., (19970000), vol. 273, pages 927 - 948 | - CHOTHIA et al., J. Mol. Biol., (19870000), vol. 196, pages 901 - 917 | - AL-LAZIKANI et al., J. Mol. Biol., (19970000), vol. 273, pages 927 - 948 | - KOHLER, Nature, (19750000), vol. 256, page 495 | - J. Biomed. Sci., (20020000), vol. 9, pages 631 - 638 | - KLEIN et al., mAbs, (20120000), vol. 4, no. 6, pages 1 - 11 | - BASELGA et al., Cancer Res, (19980000), vol. 58, no. 13, pages 2825 - 2831 |